ID CORE XT
Report
- Report Number
- 3006413195-2020-00010
- Event Type
- Malfunction
- Date Received
- July 29, 2020
- Date of Event
- June 27, 2020
- Report Date
- June 29, 2020
- Manufacturer
- PROGENIKA BIOPHARMA S.A.
- Product Code
- PEP
- UDI-DI
- 08437013457019
- PMA / PMN Number
- BP170154
- Removal / Correction Number
- N/A
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS IH CENTER FOR SEQUENCING. NEXT GENERATION SEQUENCING INTERROGATED RH GENES PROXIMAL PROMOTER, EXONS 1-10, AND PORTIONS OF INTRON 2-3. NO VARIANT WAS FOUND IN RH GENES AND SEQUENCING PROVIDED A GENOTYPE RHCE*CE, RHCE*CE, BUT ID CORE XT REPORTED A GENOTYPE RHCE*CE, RHCE*CE. ID CORE XT DETERMINES C/C ANTIGENS INTERROGATING POLYMORPHISM RHCE: C.335+3039INS109 IN RHCE GENE INTRON 2. THE PRESENCE OF THE 109 BP INSERT IS ASSOCIATED WITH C ANTIGEN. HOWEVER, THIS SAMPLE CARRIES A RARE ALLELE DESCRIBED BY ISBT AS RHCE*02.37 THAT PROVIDES A C+ PHENOTYPE BY LACKS THE 109 BP INSERT. ID CORE XT REPORTED A PREDICTED C- PHENOTYPE, BUT THE SEROLOGY DATA FROM THE USER IS C+, DUE TO THE PRESENCE OF RARE RHCE*02.37 ALLELE. SINCE ID CORE XT OBTAINED A FALSE NEGATIVE RESULT, THIS IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS LIMITATION IS COVERED BY THE GENERAL ASSAY LIMITATION DESCRIBED IN THE ID CORE XT PACKAGE INSERT (LIMITATION 1).
THE CUSTOMER REPORTED A POSSIBLE DISCREPANCY. THE SEROLOGICAL PHENOTYPE WAS C POSITIVE AND THE ID CORE XT GENOTYPE SUGGESTED A PHENOTYPE OF C NEGATIVE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 801862 | ID CORE XT | ID CORE XT | PEP | PROGENIKA BIOPHARMA S.A. | 1021720000 | 0203000019 | 08437013457019 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |